FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 5 R

MDR report key: 14346313 · Received May 10, 2022

Report

Report Number
3005180920-2022-00351
Event Type
Injury
Date Received
May 10, 2022
Date of Event
April 11, 2022
Report Date
May 10, 2022
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030825866
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 13 APRIL 2022: LOT 1905069: 80 ITEMS MANUFACTURED AND RELEASED ON 04-OCT-2019. EXPIRATION DATE: 2024-SEP-23. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 73 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT. ADDITIONAL DEVICES INVOLVED BATCH REVIEWS PERFORMED ON 13 APRIL 2022: GMK-SPHERE 02.07.1205R TIBIAL TRAY FIXED CEMENTED # 5 R LOT. 1908382 (K090988): LOT 1908382: 77 ITEMS MANUFACTURED AND RELEASED ON11-FEB-2020. EXPIRATION DATE: 2025-FEB-01. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 75 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT. GMK-SPHERE 02.07.0035RP PATELLA RESURFACING SIZE 3 LOT. 1908306 (K090988): LOT 1908306: 240 ITEMS MANUFACTURED AND RELEASED ON 07-NOV-2019. EXPIRATION DATE: 2024-OCT-15. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 236 ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT.

Description of Event or Problem · 0

THE PATIENT CAME IN REPORTING PAIN AND SWELLING. THE SURGEON DECIDED TO REVISE THE PATIENT AND DISCOVERED THAT ALL IMPLANTS WERE LOOSE AND DID NOT BOND WITH THE CEMENT. THE CAUSE OF THIS IS UNKNOWN. AT 1 YEAR AND 11 MONTHS AFTER THE PRIMARY SURGERY, THE SURGEON REVISED ALL IMPLANTS AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1294801 GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 5 R KNEE FEMORAL IMPLANT JWH MEDACTA INTERNATIONAL SA 02.12.0005R 1905069 07630030825866

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention